|Articles|June 15, 2009
Retina Roundtable Session 1
Advertisement
Subscribe
In this first session, the experts discuss their standard approach when using ranibizumab (Lucentis, Genentech) to treat their patients with age-related macular degeneration.
Participants include:
Return to 
Return to 
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
 
 



























